The compounds [{CuL(X)}2](X = Cl 1 or Br 2, HL = pyridine-2-carbaldehyde thiosemicarbazone) have been synthesised and structurally characterized. Both crystallize in the triclinic space group P. For compound 1, a= 7.915(3), b= 8.262(5), c= 9.016(2)Å, α= 67.97(3), β= 92.26(2), γ= 71.33(4)°, Z= 2, R= 0.046, R′= 0.054. For 2, a= 7.617(1), b= 8.451(3), c= 8.966(2)Å, α= 68.50(2), β= 95.94(1), γ= 71.73(2)°, Z= 2, R=R′= 0.035. The copper(II) ions have square-pyramidal environments with the tridentate thiosemicarbazone ligands and the halide atoms in an equatorial position. The sulfur atom of the tridentate ligand acts as a bridging ligand occupying the apical position of the symmetric copper atom in the dimeric structure. Such a disposition of the sulfur bridges is very scarce. Q-Band ESR spectra of the two compounds show rhombic signals with g1= 2.183, g2= 2.053, g3= 2.033 for 1 and g1= 2.161, g2= 2.057, g3= 2.033 for 2. Magnetic measurements on 1 and 2 show antiferromagnetic couplings between the copper(II) cations through the sulfur bridges. The exchange parameter is J/k=–6.8K (–4.7 cm–1). Magnetostructural correlations have been analysed by using extended Hückel molecular orbital calculations.
No takes yet. Share an insight, caveat, or question.
García‐Tojal et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: